Digestive Diseases and Sciences

, Volume 51, Issue 12, pp 2165–2169 | Cite as

Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease

  • Isabel Bernal
  • Eugeni Domènech
  • Esther Garcia-Planella
  • Laura Marín
  • Míriam Mañosa
  • Mercè Navarro
  • Eduard Cabré
  • Miquel A. Gassull
Original Article

Abstract

Recent studies have shown a low adherence rate to maintenance treatment in patients with inflammatory bowel disease (IBD). We sought to assess the medication-taking behavior in a cohort of patients with IBD. We prospectively included IBD patients from the outpatient clinic who agreed to answer a questionnaire about prescribed treatment and adherence. Physicians registered clinical data including prescribed medications. Two hundred fourteen patients (115 Crohn's disease/99 ulcerative colitis) were included. The most prescribed medications were oral mesalazine (56.5%) and immunomodulators (41.1%). Forty-three percent of patients admitted to occasionally forgetting to take their medication but only 7.5% of them did it voluntary. Oral mesalazine and azathioprine were the drugs with the poorest compliance, with nonadherence rates of 45% and 25% of the total prescribed doses, respectively. The only factor associated with a better adherence was a more complicated course of the disease—steroid dependency, steroid refractoriness, need for infliximab treatment, hospitalization, or surgery (P=.02). Twenty percent of patients admitted to self-medicating. An important proportion of patients with IBD admit to forget some doses of the prescribed medication in the setting of a specialized unit of a referral centre.

Keywords

Inflammatory bowel disease Ulcerative colitis Crohn's disease Adherence Compliance Self-medication Mesalazine Azathioprine 

References

  1. 1.
    Haynes RB (2001) Improving patient adherence: state of the art, with a special focus on medication taking for cardiovascular disorders. In: Compliance in Health Care and research. Burke LE, Ockene IS, eds. New York: Futura Publishing; pp 3–21Google Scholar
  2. 2.
    Van Hees PA, Van Tongeren JH (1982) Compliance to therapy in patients on a maintenance dose of sulphasalazine. J Clin Gastroenterol 4:333–336CrossRefPubMedGoogle Scholar
  3. 3.
    Kane SV, Cohen RD, Aikens JE, Hanauer SB (2001) Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 96:2933Google Scholar
  4. 4.
    Nigro G, Angelini G, Grosso SB, Caula G, Sategna-Guidetti C (2001) Psychiatric predictors of noncompliance in inflammatory bowel disease. Psychiatry and compliance. J Clin Gastroenterol 32:66–68CrossRefPubMedGoogle Scholar
  5. 5.
    Farup PG, Hovde O, Halvorsen FA, et al (1995) Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 30:164–170PubMedGoogle Scholar
  6. 6.
    Riley SA, Mani V, Goodman MJ, Lucas S (1990) Why do patients with ulcerative colitis relapse? Gut 31:179–183.PubMedGoogle Scholar
  7. 7.
    DiMatteo MR (1997) Adherence to treatment. In: Feldman MD, Christensen JF, eds. Behavioral medicine. A primary care handbook. New York: Appleton & Lange; 136–140Google Scholar
  8. 8.
    Kane SV (2006) Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 23:577–585CrossRefPubMedGoogle Scholar
  9. 9.
    Shale MJ, Riley SA (2003) Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 18:191–198CrossRefPubMedGoogle Scholar
  10. 10.
    Kane S, Huo D, Aikens J, Hanauer S (2003) Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 114:39–43CrossRefPubMedGoogle Scholar
  11. 11.
    Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF (1996) Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8:1179–1183PubMedGoogle Scholar
  12. 12.
    Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497CrossRefPubMedGoogle Scholar
  13. 13.
    Sewitch MJ, Abrahamowicz M, Barkun A, et al (2003) Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 98:1535–1544CrossRefPubMedGoogle Scholar
  14. 14.
    López San Román A, Bermejo F, Carrera E, Pérez-Abad M, Boixeda D (2005) Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 97:249–257PubMedGoogle Scholar
  15. 15.
    Kane S, Huo D, Magnanti K (2003) A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol 1:170–173CrossRefPubMedGoogle Scholar
  16. 16.
    Mackner LM, Crandall WV (2005) Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 11:1006–1011CrossRefPubMedGoogle Scholar
  17. 17.
    Bloomfeld RS, Onken JE (2003) Mercaptopurine metabolite results in clinical Gastroenterology practice. Aliment Pharmacol Ther 17:69–73CrossRefPubMedGoogle Scholar
  18. 18.
    Kane SV, Hanauer SB (2001) National adherence rates with IBD therapy: PO vs PR. Am J Gastroenterol 96:s296CrossRefGoogle Scholar
  19. 19.
    Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296–1310CrossRefPubMedGoogle Scholar
  20. 20.
    Gasche C, Scholmerich J, Brynskov J, et al (1998) A simple classification of Crohn's disease: report of the working party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 5:8–15Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Isabel Bernal
    • 1
  • Eugeni Domènech
    • 1
  • Esther Garcia-Planella
    • 1
  • Laura Marín
    • 1
  • Míriam Mañosa
    • 1
  • Mercè Navarro
    • 1
  • Eduard Cabré
    • 1
  • Miquel A. Gassull
    • 1
  1. 1.Gastroenterology DepartmentHospital Universitari Germans Trias i PujolBadalonaSpain

Personalised recommendations